2024-09-24 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis

**Company Overview:** CVS Health Corp is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and health insurance.

**1. Performance Analysis:**

* **Cumulative Return:** CVS has experienced a cumulative return of -34.28%, while the S&P 500 (VOO) has generated a cumulative return of 133.1%. 
* **Performance Gap:** CVS has underperformed the S&P 500 by -167.38% (compared to the historical range of -167.38 to 12.89). This means that CVS has significantly underperformed the market over the historical period.

**2. Recent Price Movement:**

* **Closing Price:** $57.57
* **5-Day Moving Average:** $57.89
* **20-Day Moving Average:** $57.65
* **60-Day Moving Average:** $58.21

The price is currently trading below the 5-day and 20-day moving averages, indicating short-term downward pressure. However, it's above the 60-day moving average, suggesting potential for a rebound in the longer term.

**3. Technical Indicators:**

* **RSI:** 50.89, indicating a neutral market sentiment.
* **PPO:** 0.12, suggesting a slight bullish signal.
* **Delta_Previous_Relative_Divergence:** -2.03, indicating a recent short-term decline in relative performance.
* **Expected_Return:** 0%, suggesting a neutral outlook for potential returns within the next 5 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings for the quarter ending August 7, 2024, were $1.83, exceeding the expected EPS of $1.73. This positive surprise indicates strong performance, potentially driving future growth. 

However, the previous quarters show a mixed pattern of beating and falling short of expectations. 

**5. Overall Analysis:**

CVS Health Corp has significantly underperformed the market, with a negative cumulative return compared to the S&P 500. While its recent earnings beat expectations, the performance in the past quarters was inconsistent. The current price movement suggests a potential for a rebound in the long term but a short-term downward trend. Technical indicators are neutral, with RSI suggesting neutral sentiment and PPO indicating slight bullish signals. The expected return is neutral.

**6. Conclusion:**

CVS Health Corp presents a mixed picture for investors. While recent earnings were positive, the company's overall performance has been lagging behind the market. The current price movement is uncertain, with potential for both upward and downward trends. Investors should carefully consider the company's future prospects and the ongoing market conditions before making any investment decisions. 
